Skip to content
Search

Latest Stories

PSNI launches consultation on changes to entry requirements for independent prescribing courses

The Pharmaceutical Society of Northern Ireland (PSNI) has begun a consultation on changes to requirements for training as a pharmacist independent prescriber and being annotated as an independent prescriber on the Register of Pharmaceutical Chemists.

The eight-week public consultation running was launched on Monday (April 4) and will run from until 12-noon on May 30, 2022.


The outline of the proposed consultation:

  • to decide in principle to remove the requirement set out in the Pharmaceutical Society of Northern Ireland (General) Regulations (Northern Ireland) 1994, (the Regulations), that a pharmacist must be on the Register for two years or more before they can be annotated as an IP;
  • to remove the two-year requirement for entry onto stand-alone pharmacist independent prescribing courses, contained in the Standards for the Education and Training of Independent Prescribers, replacing it with an assessment, by course providers, of competence to enter the course; and
  • to remove the requirement to have relevant experience in a specific clinical or therapeutic area and to replace it with the requirement to have relevant experience in appropriate clinical setting(s).

Dr Jim Livingstone, president of the Council of PSNI, said: “There have been significant changes in pharmacy education and training in the last 18 months. These include the introduction of new Initial Education and Training Standards for pharmacists and the introduction of a Foundation Training Year to replace pharmacist pre-registration training.

“The Governments in the United Kingdom have set a clear direction which will see pharmacist independent prescribers becoming increasingly important in the delivery of pharmacy services. This has led to one of the major changes in new standards for the initial education and training of pharmacists. Once these standards have been implemented in full, it will mean that all trainees will become independent prescribers at the point of joining our register.

“The proposed changes in this consultation arise from this development and seek to ensure that the present requirements for annotating the Register are appropriate and workable. It also makes proposals to revise the Standards for Education and Training of pharmacist independent prescribers, for stand-alone independent prescribing courses.

“The Council of the Pharmaceutical Society NI is clear that our primary objective is to protect patients and the public. We are also clear that wherever possible meeting this objective should not be an obstacle to innovation within the pharmacy profession and the development of healthcare services, which will benefit the public. We consider that the proposed changes will ensure the standards can meet the requirements of future service delivery and the development of the profession, whilst maintaining public and patient safety.

“We will continue to work closely with our colleagues in the GPhC in this important area and I would encourage pharmacists, patients and all interested groups to respond to this consultation”.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less